Limitations of body mass index to assess body composition due to sarcopenic obesity during leukemia therapy

Etan Orgel(Children's Hospital of Los Angeles), Steven D. Mittelman(Mattel Children's Hospital), Richard Sposto(Children's Hospital of Los Angeles), Nicole M. Mueske(Children's Hospital of Los Angeles), Vicente Gilsanz(Children's Hospital of Los Angeles), David R. Freyer(University of Southern California)

Leukemia & lymphoma/Leukemia and lymphoma

January 27, 2016

10.3109/10428194.2015.1136741

Cited by 98

Related Papers

Randomized Study of Two Chemotherapy Regimens for Treatment of Low-Grade Glioma in Young Children: A Report From the Children's Oncology Group

|Journal of Clinical Oncology|2012|433

Results of the randomized international FAB/LMB96 trial for intermediate risk B-cell non-Hodgkin lymphoma in children and adolescents: it is possible to reduce treatment for the early responding patients

|Blood|2006|431

Platinum-Induced Ototoxicity in Children: A Consensus Review on Mechanisms, Predisposition, and Protection, Including a New International Society of Pediatric Oncology Boston Ototoxicity Scale

|Journal of Clinical Oncology|2012|375

Late mortality and chronic health conditions in long-term survivors of early-adolescent and young adult cancers: a retrospective cohort analysis from the Childhood Cancer Survivor Study

|The Lancet Oncology|2020|370

Results of a randomized international study of high-risk central nervous system B non-Hodgkin lymphoma and B acute lymphoblastic leukemia in children and adolescents

|Blood|2006|362